Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

在多发性硬化症中发生轴突损失.

N Scolding1, R Franklin

  • 1University of Cambridge Neurology Unit, Addenbrooke's Hospital, UK.

Lancet (London, England)
|August 26, 1998
PubMed
概括

No abstract available in PubMed .

相关实验视频

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Unveiling the Mysteries of Ameloblastoma: A Comprehensive Case Series on Odontogenic Lesions.

Journal of pharmacy & bioallied sciences·2025
Same author

Salivary duct carcinoma in the submandibular gland: A rare case report with differential diagnosis.

Journal of oral and maxillofacial pathology : JOMFP·2024
Same author

Anti-cancer effects of green synthesized gold nanoparticles using leaf extract of <i>Annona muricata</i>. L against squamous cell carcinoma cell line 15 through apoptotic pathway.

Dental research journal·2024
Same author

Evaluation of the cytotoxic, anti-proliferative, anti-metastatic and pro-apoptotic effect of aqueous leaf extract of <i>Annona muricata</i> on oral tongue squamous cell carcinoma cell line (SCC-15): An <i>in vitro</i> study.

Journal of oral and maxillofacial pathology : JOMFP·2023
Same author

LP2, a stable lanthipeptide derived from cAng-(1-7), exerts myeloprotective action in mice.

European journal of haematology·2023
Same author

KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis.

Journal of neurology·2021
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
查看所有相关文章